• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JACC Basic Transl Sci. COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestati

tetano

Editor, Senior Moderator
JACC Basic Transl Sci. 2020 Apr 10. doi: 10.1016/j.jacbts.2020.04.002. [Epub ahead of print]
COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies.


Atri D[SUP]1[/SUP], Siddiqi HK[SUP]1[/SUP], Lang J[SUP]1[/SUP], Nauffal V[SUP]1[/SUP], Morrow DA[SUP]1[/SUP], Bohula EA[SUP]1[/SUP].

Author information




Abstract

The coronavirus disease-2019 (COVID-19), a contagious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), has reached pandemic status. As it spreads across the world, it has overwhelmed healthcare systems, strangled the global economy and led to a devastating loss of life. Widespread efforts from regulators, clinicians and scientists are driving a rapid expansion of knowledge of the SARS-CoV2 virus and the COVID-19 disease. We review the most current data with a focus on our basic understanding of the mechanism(s) of disease and translation to the clinical syndrome and potential therapeutics. We discuss the basic virology, epidemiology, clinical manifestation, multi-organ consequences, and outcomes. With a focus on cardiovascular complications, we propose several mechanisms of injury. The virology and potential mechanism of injury form the basis for a discussion of potential disease-modifying therapies.
? 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation.



KEYWORDS:

ACE2, angiotensin-converting enzyme 2; ARDS, acute respiratory distress syndrome; CDC, Centers for Disease Control; CFR, case fatality rate; COVID-19; COVID-19, coronavirus disease-2019; Cardiovascular; CoV, coronavirus; DIC, disseminated intravascular coagulation; ER, endoplasmic reticulum; ICU, intensive care unit; SARS-CoV1 or 2, severe acute respiratory syndrome coronavirus-1 or -2; SARS-CoV2; SOFA, sequential organ failure assessment; TMPSS2, trasmembrane serine protease-2; Treatments; Virology; hsCRP, high sensitivity c-reactive protein


PMID:32292848PMCID:PMC7151394DOI:10.1016/j.jacbts.2020.04.002
Free PMC Article
 
Back
Top Bottom